MENU
+Compare
VTGN
Stock ticker: NASDAQ
AS OF
Nov 28 closing price
Price
$4.90
Change
+$0.36 (+7.93%)
Capitalization
179.31M

VTGN VistaGen Therapeutics Forecast, Technical & Fundamental Analysis

Vistagen Therapeutics Inc is a biotechnology firm... Show more

Industry: #Biotechnology
VTGN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for VTGN with price predictions
Nov 28, 2025

Aroon Indicator for VTGN shows an upward move is likely

VTGN's Aroon Indicator triggered a bullish signal on November 10, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 146 similar instances where the Aroon Indicator showed a similar pattern. In of the 146 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 17, 2025. You may want to consider a long position or call options on VTGN as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for VTGN just turned positive on November 18, 2025. Looking at past instances where VTGN's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VTGN advanced for three days, in of 253 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VTGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VTGN broke above its upper Bollinger Band on November 17, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VTGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.917) is normal, around the industry mean (27.168). P/E Ratio (0.000) is within average values for comparable stocks, (52.496). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.897). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (222.222) is also within normal values, averaging (334.447).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VTGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
VTGN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of embryonic stem cells for drug discovery and development

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
343 Allerton Avenue
Phone
+1 650 577-3600
Employees
33
Web
https://www.vistagen.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMFL0.08N/A
N/A
American Films, Inc.
MCBK26.50N/A
N/A
Madison County Financial, Inc.
ABMRF33.42N/A
N/A
ABN Amro Group NV
SBFFY28.59N/A
N/A
SBM Offshore NV
CLRPF2.50N/A
N/A
Clarity Pharmaceuticals Ltd.

VTGN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with IPSC. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
+7.93%
IPSC - VTGN
41%
Loosely correlated
+0.98%
IMNM - VTGN
40%
Loosely correlated
-1.13%
SYRE - VTGN
40%
Loosely correlated
+0.84%
REPL - VTGN
38%
Loosely correlated
-0.60%
BEAM - VTGN
37%
Loosely correlated
+1.20%
More